State Medicaid Outpatient Drug Utilization and Spending for 2020

U.S. state-level data reports drug utilization for Medicaid-covered outpatient prescriptions in 2020. The dataset likely contains state identifiers, drug names, National Drug Codes, prescription counts, and reimbursement amounts. It is provided by the U.S. Department of Health & Human Services and was last updated on the platform in April 2026.

Use Cases

• Analyze state-level prescription volumes and costs based on reported drug name and reimbursement data.
• Compare Medicaid drug spending across states based on the state and dollars reimbursed fields.
• Track specific drug utilization using the National Drug Code (NDC) identifier.
• Investigate patterns in outpatient drug coverage and reimbursement under the Medicaid Drug Rebate Program.

Strengths

• Data is sourced from the authoritative U.S. Department of Health & Human Services.
• Covers the full year 2020, providing a complete annual snapshot.
• Includes key financial and utilization metrics: number of prescriptions and dollars reimbursed.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by state Medicaid agencies for the Medicaid Drug Rebate Program.

Time Range

2020

Freshness

Last updated 2026-04 08 20:29:07.503037; freshness should be verified.

Geography

United States (state-level)